Review Article

Patient, Surgery, and Hospital Related Risk Factors for Surgical Site Infections following Total Hip Arthroplasty

Table 1

Studies of risk factors for surgical site infection in patients undergoing total hip arthroplasty (THA).

StudyTypeNumber of THAs Risk factors identified

Berbari et al. [42]Retrospective526Superficial surgical site infection, NNIS index score ≥1, malignancy, prior arthroplasty.

Bongartz et al. [37]Retrospective328 Revision surgery, prolonged duration of surgery, previous joint infection, and rheumatoid arthritis.

Bozic et al. [19]Retrospective40,919Obesity, rheumatologic disease, coagulopathy, and preoperative anemia.

Bozic et al. [63]Retrospective57,047 THAs with different bearing surfacesMetal-on-metal bearing surfaces.

Carroll et al. [17]Retrospective453Obesity, allogeneic blood transfusion, coagulation with warfarin, and surgical skin preparation with 0.5% chlorhexidine in 70% alcohol.

Choong et al. [20]Retrospective819Obesity and presence of >2 comorbidities.

Cordero-Ampuero 
and de Dios [8]
Retrospective47Older age, systemic corticosteroid treatment, prolonged duration of surgery, trauma, malignancy, liver disease, alcohol abuse, IV drug abuse, inadequate antibiotic prophylaxis, persistent wound secretion, dislocation, skin infection, urinary tract infection, abdominal infection, and pneumonia.

Dale et al. [11]Retrospective432,168Trauma, male gender, hybrid fixation, cement without antibiotics, inflammatory arthritis, and avascular necrosis.

Dowsey and Choong [21]Retrospective1,207Obesity.

Font-Vizcarra et al. [26]Prospective402BMI ≥ 35.

Friedman et al. [22]Retrospective12,355Obesity.

Geubbels et al. [69]Prospective13,608 THAs and hemiarthroplastiesLow annual institution volume.

Gilson et al. [39]Retrospective22 patients receiving TNFa blockers subjected to hip, knee, shoulder, and ankle arthroplastyTreatment with TNFa blockers.

Smith et al. [53]Prospective308 THAs and TKAsAllogeneic WBC-filtered blood transfusion.

Iorio et al. [35]Retrospective1,659Diabetes.

Jafari et al. [45]Retrospective55 THAs and TKAsPrevious joint infection.

Jiang et al. [43]Retrospective878 THAsLiver cirrhosis.

Katz et al. [70]Retrospective58,521Low institution volume and low surgeon volume.

Lai et al. [31]Retrospective22Diabetes and presence of >2 comorbidities.

Lee et al. [72]Retrospective74Admission from a healthcare facility.

Malinzak et al. [9]Retrospective2,775Younger age, diabetes, and obesity.

Maoz et al. [23]Retrospective3,672 primary THAs, 406 revision THAsObesity, revision surgery, prolonged duration of surgery, and non-same day surgery.

McDougall et al. [59]Retrospective1,047Anticoagulation with warfarin or IV heparin.

Momohara et al. [38]Retrospective81Treatment with TNFa blockers and longer duration of rheumatoid arthritis.

Mraovic et al. [24]Retrospective101 THAs and TKAs versus 1,847 controlsDiabetes, obesity, prolonged duration of surgery, presence of >2 comorbidities, history of myocardial infarction, congestive heart failure, and renal insufficiency.

Muilwijk et al. [71]Retrospective15,906Low surgeon volume.

Namba et al. [14]Retrospective30,491Obesity, female gender, ASA score ≥3, and bilateral THAs.

Newman et al. [55]Retrospective1,622Allogeneic blood transfusion.

Ong et al. [12]Retrospective39,929Prolonged duration of surgery, Charlson index >5, male gender, and lower socioeconomic status.

Parvizi et al. [60]Retrospective35INR > 1.5.

Patel et al. [27]Retrospective1,221Obesity, coagulation with LMWH, and increased drain tube loss.

Peel et al. [18]Prospective36Obesity, superficial surgical site infection, increased drain tube loss, and systemic corticosteroid treatment.

Poultsides et al. [10]Retrospective412,356Malignancy, coagulopathy, liver disease, male gender, congestive heart failure, fluid and electrolyte disorders, pulmonary circulatory disease, and minority race.

Pulido et al. [25]Retrospective5,060Obesity, allogeneic blood transfusion, urinary tract infection, history of myocardial infarction, renal insufficiency, bilateral THAs, postoperative atrial fibrillation, and prolonged hospitalization.

Ridgeway et al. [6]Prospective16,291 primary THAs, 2,550 revision THAsOlder age, prolonged duration of surgery, trauma, and ASA score ≥3.

Saleh et al. [28]Prospective33 THAs and TKAs Hematoma formation and persistent drainage.

Song et al. [34]Retrospective3,422Diabetes, revision surgery, prolonged duration of surgery, and trauma.

Sousa et al. [49]Prospective1,248 THAsAsymptomatic bacteriuria.

van Kasteren et al. [30]Prospective1,922Prolonged duration of surgery, ASA score ≥3, and administration of prophylactic antibiotics after incision.

Willis-Owen et al. [13]Prospective1,750Male gender and prolonged duration of surgery.

Wu et al. [7]Retrospective198Older age, diabetes, obesity, alcohol abuse, and rural residence.